The assessment and treatment of refractory anxiety
- PMID: 7915712
The assessment and treatment of refractory anxiety
Abstract
Most patients with anxiety disorders can be effectively treated with the use of specific pharmacologic and psychological approaches. Nevertheless, some anxiety patients remain refractory to standard treatments. For these patients, reappraisal and a systematic approach can be helpful. A common problem in patients with "treatment-resistant" anxiety is the use of inadequate doses or inadequate duration of medication treatment. Alternatively, the diagnosis may need to be reconsidered, and comorbid diagnoses carefully assessed. Comorbid psychiatric, medical, and neurologic conditions may complicate the treatment of anxiety or require additional specific treatments. Finally, alternative pharmacologic approaches for specific types of anxiety can yield successful outcomes.
Similar articles
-
The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.Depress Anxiety. 2008;25(2):91-7. doi: 10.1002/da.20279. Depress Anxiety. 2008. PMID: 17311265
-
Anxious depression.J Clin Psychiatry. 1998;59 Suppl 18:10-7. J Clin Psychiatry. 1998. PMID: 9840193 Review.
-
Therapeutic strategies for the patient with treatment-resistant anxiety.J Clin Psychiatry. 1993 May;54 Suppl:69-74. J Clin Psychiatry. 1993. PMID: 8509358 Review.
-
[Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].Encephale. 2002 Nov-Dec;28(6 Pt 1):510-9. Encephale. 2002. PMID: 12506263 Clinical Trial. French.
-
Pharmacotherapy of anxious disorders.Hum Psychopharmacol. 2002 Dec;17(8):383-400. doi: 10.1002/hup.435. Hum Psychopharmacol. 2002. PMID: 12457374 Review.
Cited by
-
Anxiety Disorders in Neurologic Illness.Curr Treat Options Neurol. 2001 Jul;3(4):333-346. doi: 10.1007/s11940-001-0038-1. Curr Treat Options Neurol. 2001. PMID: 11389804